What is the main business of MGM Pharma?

The main business activity of MGM Pharma focuses on activities of head office and holding companies, excluding financial holding companies.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on July 28, 2014.

Where is the headquarters located?

The headquarters is located at: ul. Aleksandrowska 42, 95-070 Rąbień.

What is the share capital?

The share capital of the company is PLN 6,000 (approx. $1,621).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What was the revenue?

The company reported a revenue of $15,418 in 2025, which is a decrease of 6.1% compared to 2024.

Is the company profitable?

Yes, in 2025 the company was profitable, achieving a net profit of $12,222, meaning the company decreased its profit by 4.3%.

What is the main operating cost?

The largest operating cost category falls under other operating costs. This category amounted to $1,693 in 2025, representing 100% of all operating expenses.

MGM Pharmasp. z o.o.

Activities of head office and holding companies, excluding financial holding companies

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2014-07-28

Share capital

6,000.00 PLN

Activity description

MGM Pharma distributes chemical raw materials and produces dietary supplements and medicinal products. The company advises on registering supplements, cosmetics and medicinal products, and checks the quality of its raw materials; BIO-certified ingredients are available on request.

Registered address

ul. Aleksandrowska 42, 95-070 Rąbień, Poland

Website

mgmpharma.pl

Phone

Electronic delivery address

AE:PL-73153-89946-JUFID-27

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 112 days early.

202512/03/2026
202406/03/2025
202317/06/2024
202217/04/2023
202124/03/2022
202013/04/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 15.42kMedianUSD 29.17kAverageUSD 6.02m

Net profit

This companyUSD 12.22kMedianUSD 322.23AverageUSD 826.80k

Operating costs

This companyUSD 1.69kMedianUSD 14.45kAverageUSD 4.70m

Assets

This companyUSD 14.71kMedianUSD 86.67kAverageUSD 17.29m

Industry

Offer

Plant extracts
Dietary supplement additives
Tablet fillers
Ingredients for sports nutrition

Clients and partners

Authorized Representatives

Anna Teresa Maraszek – Management Board Member

Magdalena Katarzyna Grzywniak – Management Board Member

Konrad Radomir Marcinkowski – Management Board Member

Manner of representation

In the case of a multi-member management board, each member of the management board is authorized to represent the company independently.

Ownership

Owner	Shares	Share value	Stake
Magdalena Katarzyna Grzywniakage 55	20	$540.25	33.3333%
Anna Teresa Maraszekage 52	20	$540.25	33.3333%
Konrad Radomir Marcinkowskiage 46	20	$540.25	33.3333%

Beneficial owners

Person	Rights

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Bionatursp. z o.o.	$150,929.18	bionatur.pl
Over Groupsp. z o.o.	$131,106.53	over-group.com
Ekamedicasp. z o.o.	$59,131.67	ekamedica.pl
M&M Biuro Rachunkowesp. z o.o.	$24,154.35	mmksiegowosc.pl
Mazuleksp. z o.o.	$15,841.76	mazulek.pl
Genesis Pharmsp. z o.o.	$2,762.43	genesispharm.eu

Change history

Date	Event
2024-07-09	Address change (Łąkowa 19, 90-554, M. Łódź → Ul. Aleksandrowska 42, 95-070, Rąbień)
2020-10-22	PKD change (Removed: 96.09.Z)
2014-07-28	Entered in the register

FAQ

Last updated: 2026-10-07